Naimil Shah

Naimil Shah is the 'Product Guy' at Coral AI — an IIM Ahmedabad MBA who pivoted from VC at Chiratae Ventures to join an early-stage AI healthcare startup, with a prior stint speaking at the 2024 IndiaAI Summit on AI infrastructure and policy.

Naimil joined Coral AI in November 2025, describing it at the time as a 'rocketship' — an early-stage bet on AI-driven healthcare automation. He got there via an unusual route: a Computer Science degree from BITS Pilani (2013–2017), then data engineering at HSBC, a stint at Adani Power, and a detour through Goodera and Deloitte India before landing an MBA at IIM Ahmedabad in 2019. Post-MBA he did a product management role at Microsoft (2021–2022), then crossed to the investment side as an Associate at Chiratae Ventures (2023–2025), where he evaluated deals and amplified portfolio companies including Pepsales, Suprsend, and CtrlB. The through-line is a persistent pull between building and backing: engineering → operations → VC → product, each lap adding a new lens. He co-founded the BITS Goa Branch of 180 Degrees Consulting during his undergraduate years, leading client acquisition and training the team. Publicly, he posts on AI infrastructure, B2B sales, venture capital, and healthcare tech, and he's spoken at the 2024 IndiaAI Summit on AI policy and infrastructure and appeared at the Chiratae Startup Connect Delhi Edition in 2025 — comfortable at the intersection of product and investment conversations.

Naimil's closest visible nodes are colleagues at Coral AI — Aniket Mohanty is named as a peer leader there. From his Chiratae years, Venkatesh Peddi (Chiratae Ventures) is a named colleague. He has also publicly engaged with Yoni Rechtman of Slow Ventures in the context of Coral AI hiring, signaling some investor-side connectivity around the company.

  • Short stints across HSBC, Microsoft, Chiratae, and now Coral AI → moves deliberately toward the next learning edge rather than optimizing for tenure.
  • Hybrid role_type pattern (engineering → operations → VC → product) → likely comfortable context-switching and resists narrow job descriptions.
  • Active LinkedIn poster on AI infrastructure, B2B sales, and healthcare tech → processes thinking publicly and probably responds well to direct engagement on ideas.
  • Spoke at the IndiaAI Summit on policy and infrastructure while working in VC → brings a macro-policy lens to what is otherwise an operator role, worth noting if the conversation touches regulation.
  • Possibly — co-founding the BITS Goa branch of 180 Degrees Consulting as an undergraduate suggests he gravitates toward building new things inside larger structures, not just running existing ones.

Conversation tips

  • Reference the VC-to-operator move specifically — ask what he saw at Chiratae that made him want to be on the building side; it's a deliberate pivot he's made publicly and he'll have a clear answer.
  • He posts on AI infrastructure and B2B sales, so product and go-to-market conversations will land better than pure technical deep-dives.
  • MedTrade Conference participation signals genuine healthcare-sector immersion — not just 'AI for everything' — so domain-specific healthcare context will resonate.
  • He amplified Yoni Rechtman's Coral AI hiring post, so investor relationships around the company are live — mentioning the Slow Ventures connection is fair game.
  • Open on the VC-to-product move: he spent 2023–2025 at Chiratae Ventures evaluating deals and then chose to join an early-stage startup as 'Product Guy' in November 2025 — a deliberate bet worth unpacking.
  • Reference the IndiaAI Summit appearance in 2024, where he spoke on AI infrastructure and policy — a signal that he thinks about AI at a systems level, not just feature-by-feature.
  • Bring up the 180 Degrees Consulting BITS Goa Branch he co-founded as an undergrad — it's the earliest signal of the builder instinct that runs through his whole career.
  1. After two years evaluating startups at Chiratae, what did you see in Coral AI specifically that made you want to be inside the company rather than on the cap table?
  2. You've been at MedTrade and are clearly embedded in the healthcare DME space — what's the hardest part of the sales or adoption motion for AI tools with healthcare operators?
  3. Your content themes span AI infrastructure, B2B sales, and VC — how does the investor lens from Chiratae actually change how you approach product decisions day-to-day?

Don't treat him as a pure product person and skip the VC background — two years evaluating deals at Chiratae shapes how he thinks about market sizing and competitive dynamics, and ignoring it will make the conversation feel shallow.

Make it yours

Tailor these openers to what you sell

These openers are generic. Sign in and tell Brief what you sell — it rewrites the hooks and questions around your pitch.

Brief on your next meeting?

Type any name. Get a structured pre-meeting brief in seconds.

Try Brief →

Generated by briefthecall.com from public web sources on July 25, 2026. Each claim is linked to its source above.

Automatically generated by AI from public sources. May be inaccurate or out of date. Remove or correct this profile →